People who feel depressed are more likely to believe vaccine-related misinformation, according to a new study coauthored by a Rutgers researcher during a time when depression rates are higher due to the COVID-19 pandemic.
Jan 21, 2022
0
180
People may be willing to condone statements they know to be false and even spread misinformation on social media if they believe those statements could become true in the future, according to research published by the American ...
Apr 14, 2022
0
216
A USC analysis of tens of thousands of cannabis-related posts on Twitter found that social bots regularly perpetuated bogus health claims on the platform, illustrating how false statements may drown out solid science on social ...
Dec 19, 2019
0
18
When adults hear a statement repeated twice, they are more likely to think it is true than if they've heard it only once. This has been replicated many times in existing research studies and is known as the illusory-truth ...
Oct 7, 2020
0
4
People who think they know a lot about COVID-19 vaccines are more likely to hold vaccine misperceptions, according to a new survey from a nationwide coalition of university-based researchers.
Feb 16, 2022
0
18
Even when we know better, we often rely on inaccurate or misleading information to make future decisions. But why are we so easily influenced by false statements such as "vaccinations cause autism" or "30 million illegal ...
Aug 23, 2016
0
2
(HealthDay)—Misinformation about COVID-19 vaccines abounds, and people with depression are more likely than others to fall for it, a new study finds.
Jan 24, 2022
0
8
A new study of restaurant staff reveals low levels of food allergy knowledge and negative attitudes about serving people with food allergies, while exploring key factors that might influence such knowledge and attitudes. ...
Apr 24, 2019
0
2
The drugmaker Merck is paying $830 million to resolve a federal class-action lawsuit involving shareholders and the painkiller Vioxx, which was pulled from the market years ago over safety concerns.
Jan 15, 2016
0
0
A subsidiary of India's largest pharmaceutical company has agreed to pay a record $500 million in fines and penalties for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown ...
May 13, 2013
0
0
